CN102391253A - Synthetic technology of azelastine hydrochloride - Google Patents

Synthetic technology of azelastine hydrochloride Download PDF

Info

Publication number
CN102391253A
CN102391253A CN201110324488XA CN201110324488A CN102391253A CN 102391253 A CN102391253 A CN 102391253A CN 201110324488X A CN201110324488X A CN 201110324488XA CN 201110324488 A CN201110324488 A CN 201110324488A CN 102391253 A CN102391253 A CN 102391253A
Authority
CN
China
Prior art keywords
hydrogen
methyl
stirring
potassium borohydride
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201110324488XA
Other languages
Chinese (zh)
Inventor
陈友
黄忠文
刘诚
李占胜
倪全平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUIZHOU YUNFENG PHARMACEUTICAL CO Ltd
Original Assignee
GUIZHOU YUNFENG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUIZHOU YUNFENG PHARMACEUTICAL CO Ltd filed Critical GUIZHOU YUNFENG PHARMACEUTICAL CO Ltd
Priority to CN201110324488XA priority Critical patent/CN102391253A/en
Publication of CN102391253A publication Critical patent/CN102391253A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthetic technology of azelastine hydrochloride, which is characterized in that acylhydrazone is formed by N-Methylhexahydroazepin-4-one hydrochloride and benzoyl hydrazine and then is reduced with potassium borohydride, and finally is condensed with 2-(para chlorobenzene acetyl) benzoic acid into 4-( chlorine benzyl)-2-piperazidine-1- methyl-1H-azelastine-4- radical)-1-(2H)-phthalazine hydrochloride. The synthetic technology has the advantages of simple process and higher yield.

Description

A kind of synthesis technique of W-2979M
Technical field
The invention belongs to the fine chemistry industry production field, be specifically related to a kind of synthesis technique of W-2979M.
Background technology
The chemical formula of W-2979M is 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate; Be by German Asta-Werker AG company and the research and development exploitation of Japanese Wei Cai company, received extensive attention since the listing.This product all has production in states such as U.S.A, moral, English, day and methods at present, and takes in British Pharmacopoeia.Estimate the structure of the listing of asthma new drug W-2979M, have the huge market space and prospect present treatment of allergic rhinitis of big about-face and asthma medication, significant to the research of its technology.
Chinese Journal of Pharmaceuticals reported that with N-methyl piperidine-4-ketone be raw material in 2003, had synthesized W-2979M through reactions such as ring expansion, hydrazidesization, condensations, and overall yield of reaction is 48.6%, and this method synthetic W-2979M yield is not high.
Chinese patent CN20091014407.0 in 2009 adopts N-methyl six hydrogen, and azatropylidene-the 4-keto hydrochloride is a raw material, and through condensation one-step synthesis W-2979M, total recovery reaches 67%, but the raw material that this method adopts is more difficult to get, and yield is not high.
Summary of the invention
The present invention provides a yield height, and the simple W-2979M synthetic route of technology is one and is easy to industrialized synthetic route.
The synthesis technique of a kind of W-2979M of the present invention; Adopt N-methyl six hydrogen azatropylidene-4-keto hydrochloride and benzoyl hydrazine to form acylhydrazone; Use potassium borohydride reduction again; At last again and 2-(to chloro acetyl) phenylformic acid be condensed into 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate, its reaction equation is following:
Figure 201110324488X100002DEST_PATH_IMAGE002
The synthesis technique of a kind of W-2979M of the present invention; The reaction conditions of N-methyl six hydrogen azatropylidene-4-keto hydrochloride and benzoyl hydrazine is: the mol ratio is 1: (1 ~ 1.2); Stirring reaction 1-5h at room temperature bathes with icy salt solution or cryosel then and is chilled to-10-20 ℃.
The new synthetic process of a kind of W-2979M of the present invention; Use the condition of potassium borohydride reduction to be: the methanol solution that drips 0.5 ~ 2 mol/L KOH; 1 ~ 6h adds POTASSIUM BOROHYDRIDE 97MIN again, and the amount that adds POTASSIUM BOROHYDRIDE 97MIN is 1 ~ 1.5 times of N-methyl six hydrogen azatropylidene-4-keto hydrochloride add-on; Continue cooling and stirring after 5-50 minute, 10-50 ℃ of following stirring reaction 5 ~ 10h.
The synthesis technique of a kind of W-2979M of the present invention is used CH with the product behind the potassium borohydride reduction 2Cl 2MgSO is used in extraction 4After the drying, again with adding the diethyl ether solution salify that contains HCl, precipitation; Add pure water and 2-(to chloro acetyl) phenylformic acid again; Add-on is 0.8 ~ 1.2 times of N-methyl six hydrogen azatropylidene-4-keto hydrochloride add-on; Using 10 ~ 30% NaOH solution accent pH again is 5 ~ 9, stirring and refluxing 1 ~ 3h, under agitation cooling; Make oily matter become solid particulate, the NaOH with 10 ~ 30% transfers PH>7, the W-2979M free alkali is fully separated out, leave standstill, filter the washing after drying.
The synthesis technique of a kind of W-2979M of the present invention, dried 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate uses earlier the acetone heating for dissolving; Add gac, stirring and refluxing 10-80min, filtered while hot; Filter residue washs with hot acetone, and filtrating is used the aqueous isopropanol salify that contains HCl under cooling and stirring, freezing, filtration; Solids is used the cold acetone thorough washing, drains.80 ~ 105 ℃ of following dryings, distinguish recrystallization once with acetone and ethanol again, obtain 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate product.
The beneficial effect that the present invention reaches: the present invention adopts N-methyl six hydrogen azatropylidene-4-keto hydrochloride and benzoyl hydrazine to form acylhydrazone; Use potassium borohydride reduction again; At last again and 2-(to chloro acetyl) phenylformic acid be condensed into 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate, it is simple to have technology, yield is high; Total recovery reaches 70% ~ 80%, and the product content that obtains behind the recrystallization reaches more than 98.5%.
   
Embodiment
The synthesis technique of a kind of W-2979M of the present invention; Adopt N-methyl six hydrogen azatropylidene-4-keto hydrochloride and benzoyl hydrazine to form acylhydrazone; Use potassium borohydride reduction again, at last again and 2-(to chloro acetyl) phenylformic acid be condensed into 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate.
In reaction kettle, add N-methyl six hydrogen azatropylidene-4-keto hydrochloride 100 mol and benzoyl hydrazine 110mol, at room temperature stirring reaction 1-5h bathes with icy salt solution or cryosel then and is chilled to 0 ~ 20 ℃; Drip the methanol solution 50L of 2 mol/L KOH, the dropping time is 5h, adds POTASSIUM BOROHYDRIDE 97MIN 130mol again, continues cooling and stirring after 30 minutes, 40 ~ 50 ℃ of following stirring reaction 6h; Use CH again 2Cl 2 (50kg MgSO is used in extraction (1000ml * 3) 4After the drying, again with adding the diethyl ether solution salify that contains HCl, precipitation; Add 1000kg pure water and 2-(to chloro acetyl) phenylformic acid 100mol again, using 20% NaOH solution accent pH again is 7, stirring and refluxing 2h; Under agitation cooling makes oily matter become solid particulate, and using 20% NaOH accent PH is 9; The W-2979M free alkali is fully separated out; Leave standstill, filter, the washing after drying; Dried 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate uses earlier the acetone heating for dissolving, adds gac; Stirring and refluxing 60min, filtered while hot, filter residue washs with hot acetone; With the aqueous isopropanol salify that contains HCl, the cold acetone thorough washing is used in freezing, filtration to filtrating again under cooling and stirring; Drain,, distinguish recrystallization once with acetone and ethanol again 100 ℃ of following dryings; Obtain 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate (72kmol), content reaches: 99.1%.

Claims (6)

1. the synthesis technique of a W-2979M; It is characterized in that: adopt N-methyl six hydrogen azatropylidene-4-keto hydrochloride and benzoyl hydrazine to form acylhydrazone; Use potassium borohydride reduction again; At last again and 2-(to chloro acetyl) phenylformic acid be condensed into 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate, its reaction equation is following:
Figure 201110324488X100001DEST_PATH_IMAGE002
2. the synthesis technique of a kind of W-2979M according to claim 1; It is characterized in that: the reaction conditions of N-methyl six hydrogen azatropylidene-4-keto hydrochloride and benzoyl hydrazine is: the mol ratio is 1: (1 ~ 1.2); Stirring reaction 1-5h at room temperature bathes with icy salt solution or cryosel then and is chilled to-10-20 ℃.
3. the new synthetic process of a kind of W-2979M according to claim 1; It is characterized in that: use the condition of potassium borohydride reduction to be: the methanol solution that drips 0.5 ~ 2 mol/L KOH; 1 ~ 6h adds POTASSIUM BOROHYDRIDE 97MIN again, and the amount that adds POTASSIUM BOROHYDRIDE 97MIN is 1 ~ 1.5 times of N-methyl six hydrogen azatropylidene-4-keto hydrochloride add-on; Continue cooling and stirring after 5-50 minute, 10-50 ℃ of following stirring reaction 5 ~ 10h.
4. the synthesis technique of a kind of W-2979M according to claim 3, it is characterized in that: the product with behind the potassium borohydride reduction is used CH 2Cl 2MgSO is used in extraction 4After the drying, again with adding the diethyl ether solution salify that contains HCl, precipitation; Add pure water and 2-(to chloro acetyl) phenylformic acid again; Add-on is 0.8 ~ 1.2 times of N-methyl six hydrogen azatropylidene-4-keto hydrochloride add-on; Using 10 ~ 30% NaOH solution accent pH again is 5 ~ 9, stirring and refluxing 1 ~ 3h, under agitation cooling; Make oily matter become solid particulate, the NaOH with 10 ~ 30% transfers PH>7, the W-2979M free alkali is fully separated out, leave standstill, filter the washing after drying.
5. the synthesis technique of a kind of W-2979M according to claim 1 is characterized in that: dried 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate, the first acetone heating for dissolving of using; Add gac, stirring and refluxing 10-80min, filtered while hot; Filter residue washs with hot acetone, and filtrating is used the aqueous isopropanol salify that contains HCl under cooling and stirring, freezing, filtration; Solids is used the cold acetone thorough washing, drains.
6. 80 ~ 105 ℃ of following dryings, distinguish recrystallization once with acetone and ethanol again, obtain 4-(4-benzyl chloride base)-2-(six hydrogen-1-methyl isophthalic acid H-nitrogen Zhuo-4-yl)-1-(2H)-phthalazinium hydrochlorate product.
CN201110324488XA 2011-10-24 2011-10-24 Synthetic technology of azelastine hydrochloride Pending CN102391253A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110324488XA CN102391253A (en) 2011-10-24 2011-10-24 Synthetic technology of azelastine hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110324488XA CN102391253A (en) 2011-10-24 2011-10-24 Synthetic technology of azelastine hydrochloride

Publications (1)

Publication Number Publication Date
CN102391253A true CN102391253A (en) 2012-03-28

Family

ID=45858658

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110324488XA Pending CN102391253A (en) 2011-10-24 2011-10-24 Synthetic technology of azelastine hydrochloride

Country Status (1)

Country Link
CN (1) CN102391253A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102702108A (en) * 2012-06-27 2012-10-03 上海大学 1,2-dihydrophthalazin compound and synthetic method thereof
CN102863393A (en) * 2012-09-26 2013-01-09 上海大学 1,2-dihydro phthalazine compound and synthetic method thereof
US8937178B2 (en) 2013-03-13 2015-01-20 Flatley Discovery Lab Phthalazinone compounds and methods for the treatment of cystic fibrosis
CN112079739A (en) * 2020-09-28 2020-12-15 四川伊诺达博医药科技有限公司 Preparation method of azelastine key intermediate N-methylhexahydroazepin-4-one hydrochloride
CN113045547A (en) * 2019-12-27 2021-06-29 武汉先路医药科技股份有限公司 Preparation method of azelastine hydrochloride
CN113956239A (en) * 2021-10-28 2022-01-21 昆明源瑞制药有限公司 Azelastine hydrochloride, and preparation method and application thereof
CN114507184A (en) * 2020-11-17 2022-05-17 好医生药业集团有限公司 Synthesis method and application of 1-methylhexahydroazepin-4-one hydrochloride

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07224058A (en) * 1994-02-08 1995-08-22 Y I C:Kk Production of 4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)-1(2h)-phthalazinone or its salt
JPH07316317A (en) * 1994-05-24 1995-12-05 Toyobo Co Ltd Polyester-based film for metal laminate, laminated metal plate and metal container
KR20030020119A (en) * 2001-09-03 2003-03-08 한올제약주식회사 An improved synthetic method of azelastine
CN101987844A (en) * 2009-08-04 2011-03-23 铜陵凯顺生物科技有限公司 Method for synthesizing 4-(4-chlorobenzyl)-2-(hexahydro-1-methyl-1H-diazepoxide-4-radical)-1-(2H)-phthalizine hydrochloride

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07224058A (en) * 1994-02-08 1995-08-22 Y I C:Kk Production of 4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)-1(2h)-phthalazinone or its salt
JPH07316317A (en) * 1994-05-24 1995-12-05 Toyobo Co Ltd Polyester-based film for metal laminate, laminated metal plate and metal container
KR20030020119A (en) * 2001-09-03 2003-03-08 한올제약주식회사 An improved synthetic method of azelastine
CN101987844A (en) * 2009-08-04 2011-03-23 铜陵凯顺生物科技有限公司 Method for synthesizing 4-(4-chlorobenzyl)-2-(hexahydro-1-methyl-1H-diazepoxide-4-radical)-1-(2H)-phthalizine hydrochloride

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GERHARD SCHEFFLER ET AL: "Synthese und Kristallstrukturanalyse von Azelastin", 《ARCH. PHARM.(WEINHEIM)》 *
曹日辉等: "盐酸氮卓斯汀的合成", 《中国医药工业杂志》 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102702108A (en) * 2012-06-27 2012-10-03 上海大学 1,2-dihydrophthalazin compound and synthetic method thereof
CN102863393A (en) * 2012-09-26 2013-01-09 上海大学 1,2-dihydro phthalazine compound and synthetic method thereof
US8937178B2 (en) 2013-03-13 2015-01-20 Flatley Discovery Lab Phthalazinone compounds and methods for the treatment of cystic fibrosis
US9783529B2 (en) 2013-03-13 2017-10-10 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis
US9790215B2 (en) 2013-03-13 2017-10-17 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis
CN113045547A (en) * 2019-12-27 2021-06-29 武汉先路医药科技股份有限公司 Preparation method of azelastine hydrochloride
CN113045547B (en) * 2019-12-27 2023-03-28 武汉先路医药科技股份有限公司 Preparation method of azelastine hydrochloride
CN112079739A (en) * 2020-09-28 2020-12-15 四川伊诺达博医药科技有限公司 Preparation method of azelastine key intermediate N-methylhexahydroazepin-4-one hydrochloride
CN112079739B (en) * 2020-09-28 2023-06-02 四川伊诺达博医药科技有限公司 Preparation method of azelastine key intermediate N-methyl hexahydroazepin-4-one hydrochloride
CN114507184A (en) * 2020-11-17 2022-05-17 好医生药业集团有限公司 Synthesis method and application of 1-methylhexahydroazepin-4-one hydrochloride
CN114507184B (en) * 2020-11-17 2024-02-13 好医生药业集团有限公司 Synthesis method and application of 1-methyl hexahydroazepin-4-one hydrochloride
CN113956239A (en) * 2021-10-28 2022-01-21 昆明源瑞制药有限公司 Azelastine hydrochloride, and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN102391253A (en) Synthetic technology of azelastine hydrochloride
CN102617547A (en) Method for preparing racemic nicotine
CN103664561B (en) The preparation method of a kind of metconazole and intermediate thereof
CN102964313B (en) Synthetic method of febuxostat
CN101671292B (en) Synthetic method of fexofenadine hydrochloride
CN106866434B (en) A kind of preparation method of VENLAFAXINE HCL intermediate
CN101792387B (en) Preparation method of 2,3,4-trimethoxybenzoic acid
CN102964280B (en) Preparation method of toluenesulfonylurea
CN104447355A (en) Novel method for preparing bromhexine hydrochloride
CN104557744A (en) Preparation method of triazoie compound
CN102010325A (en) Method for synthesizing p-hydroxyphenylacetic acid
CN103992241B (en) The preparation method of N-substituted-phenyl glycine
CN104326927B (en) A kind of preparation method of 1-[2-amino-1-(4-methoxyphenyl) ethyl] Hexalin sulfate
CN101296894A (en) Novel method for preparing quaternary acid and ammonium salts
CN109384683A (en) A kind of preparation method of 2- amino-5-fluorine acetophenone
CN101735070A (en) Resolution method of R-(+)-1-(1-naphthyl) ethylamine
CN101585805A (en) Preparation method of an antiallergic agent fexofenadine hydrochloride
CN103044356A (en) New method for synthesizing levocetirizine and key intermediate thereof
CN102002028B (en) Method for synthesizing luteolin
CN101440067B (en) Preparation of medicament intermediate 1-methyl-3-phenyl piperazine
CN104628627A (en) Method for synthesizing 1-boc-4-aminopiperidine
CN100569745C (en) The method for preparing Tan Shulexin
CN104974081A (en) Synthetic method of 3-bromopyridine
CN105175250B (en) A kind of new method synthesizing ciprofibrate
CN107325039B (en) Preparation method of dexmethylphenidate hydrochloride

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120328